U.N.-Backed Agency Signs Licensing Deals for Generic Roche Flu Drug to Boost Pandemic Readiness
Source Summary
A United Nations-backed agency has entered into sub-licensing agreements for generic versions of Roche's influenza treatment as part of pandemic preparedness efforts. The deals aim to expand access to the antiviral medication ahead of potential future outbreaks.
Why it matters
Securing generic versions of antivirals in advance strengthens global capacity to respond rapidly to future influenza pandemics.
